Bulletin
Investor Alert

Protagonist Therapeutics Inc.

NAS: PTGX

GO
/marketstate/country/us

After Hours

 --Quotes are delayed by 20 min

May 26, 2023, 7:58 p.m.

/zigman2/quotes/205674595/composite

$

25.81

Change

-0.79 -1.68%

Volume

Volume 11,662

Quotes are delayed by 20 min

/zigman2/quotes/205674595/composite

Previous close

$ 25.36

$ 26.25

Change

+0.89 +3.51%

Day low

Day high

$25.21

$26.45

Open

52 week low

52 week high

$6.91

$26.87

Open

Chaitan S. Khosla

Transactions

Date Shares Transaction Value
08/11/2020 2,499   Disposition at $17.19 per share. 42,958
08/11/2020 2,499   Derivative/Non-derivative trans. at $1.89 per share. 4,723

Officers and Executives

Dr. Dinesh V. Patel
President, Chief Executive Officer & Director
Mr. Asif Ali
Chief Financial Officer & Executive Vice President
Dr. Mohammad Masjedizadeh
Chief Technical Officer & Executive VP
Dr. Arturo Molina
Chief Medical Officer
Dr. Scott Plevy
Executive Vice President & Head-Gastroenterology
Dr. Samuel R. Saks
Advisor-Clinical Development
Dr. Ashok Bhandari
Senior Director-Chemistry
Mr. Carter J. King
Senior Vice President-Business Development
Dr. Suneel Gupta
Chief Development Officer
Mr. Jami Taylor
Vice President-Corporate Affairs
Ms. Carena Spivey
Senior Vice President-Human Resources
Mr. Matthew M. Gosling
Executive Vice President & General Counsel
Mr. Craig Ostroff
Head-Regulatory Affairs
Dr. Harold E. Selick
Chairman
Ms. Sarah A. O'Dowd
Independent Director
Mr. William D. Waddill
Independent Director
Dr. Lewis T. Williams
Independent Director
Dr. Sarah B. Noonberg
Independent Director
Mr. Bryan Giraudo
Independent Director
Link to MarketWatch's Slice.